DIAGNOS Inc. ( DGNOF) - Key Metrics
DGNOF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q3 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q2 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q1 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
DGNOF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -6.85 |
| 2026Q3 | 0% | -9.17 |
| 2026Q2 | 0% | -7.06 |
| 2026Q1 | 0% | -4.06 |
| 2025Q4 | 0% | -5.41 |
DGNOF
Price: $0.31
52 week price:
Earnings Per Share: -0.04 USD
P/E Ratio: -5.50
Exchange: OQB
Sector: Healthcare
Industry: Health Information Services
Market Capitalization: 40.7 million